治疗遗传学：心理治疗的效率如何与基因型相关？

封面


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

心理治疗以及临床和心理干预的有效性取决于各种因素：专家的技能和特点；症状的诊断和严重程度；患者/客户的社会和个人特征；心理治疗接触的参数。治疗遗传学是分子遗传学与心理治疗交叉领域的应用研究领域，  它检查了心理治疗干预(无)成功的分子遗传预测因子。

目的：分析和概括治疗遗传学领域的现有研究，证实其对精神病学、心理治疗和临床心理学的理论和实践重要性，讨论现有的局限性和设计相关应用研究的要求。迄今为止已经有可能确定矛盾的，但同时有希望的模式。本文将治疗基因研究的结果系统化完全按照鉴定候选基因的方法。描述了在儿童和成人焦虑和抑郁症心理治疗中发生的基因-环境相关性。本文系统地介绍了主要按照候选基因鉴定方法进行的治疗遗传学研究的结果。规划治疗遗传学研究时，应考虑以下方法，方法和组织方面：实验样品的足够代表性-无论是在社会人口统计学特征方面，还是在诊断和所用治疗方面；对照组的存在；使用评分量表和半结构化诊断访谈来评估受访者的功能；普遍采用评估心理治疗方法结果的方案；全基因组关联搜索方法的应用；保持机密性，并向受访者提供提供心理帮助的最低有效方法。

全文:

受限制的访问

作者简介

Anna Faustova

Ryazan State Medical University

编辑信件的主要联系方式.
Email: anne.faustova@gmail.com
ORCID iD: 0000-0001-8264-3592
SPIN 代码: 5869-7409
Researcher ID: AAS-5395-2020

PhD in Psychology, Head of the Department of Clinical Psychology

俄罗斯联邦, 390026, Ryazan, 9, Vysokovol'tnaya str.

Michael Wang

University of Leicester

Email: anne.faustova@gmail.com

Honorary Consultant Clinical Neuropsychologist, Emeritus Professor of Clinical Psychology

英国

参考

  1. Pugovkina OD, Nikitina IV, Holmogorova AB, et al. Academic research of therapy process and efficient: History and main topics. Moskovskiy Psikhoterapevticheskiy Zhurnal. 2009;(1):35-68. (In Russ).
  2. Regier DA, Kuhl EA, Kupfer DJ. The DSM-5: Classification and criteria changes. World Psychiatry. 2013;12(2):92-8. doi: 10.1002/wps.20050
  3. ICD-11 for Mortality and Morbidity Statistics (ICD-11 MMS). Available at: https://icd.who.int/browse11/l-m/en. Accessed: 2020 September 25.
  4. Russell RL, Orlinsky DE. Psychotherapy research in historical perspective. Implications for mental health care policy. Archives of General Psychiatry. 1996;53(8):708-15. doi: 10.1001/archpsyc.1996.01830080060010
  5. Eysenck HJ. The effects of psychotherapy: An evaluation. Journal of Consulting Psychology. 1952;16(5):319-24. doi: 10.1037/h0063633
  6. Wallerstein RS. The psychotherapy research prоjet (PRP) of the Menninger Foundation: An overview. Journal of Consulting and Clinical Psychology. 1989;57(2):195-205.
  7. Ayzenk GDzh. Sorok let spustya: novyy vzglyad na problemy effektivnosti v psikhoterapii. Psikhologicheskiy Zhurnal. 1994;14(4):3-19. (In Russ).
  8. Kholmogorova AB. Two conflicting methodologies in the studies of psychotherapy and its efficiency: looking for a third way A.B. Kholmogorova. Part I. Moskovskiy Psikhoterapevticheskiy Zhurnal. 2009; (4):5-25. (In Russ).
  9. Kholmogorova AB, Garanyan NG, Nikitina IV, et al. Research concerning the process of psychotherapy and its efficacy: current situation. Part 2. Sotsial’naya i Klinicheskaya Psikhiatriya. 2010;20 (1):70-9. (In Russ).
  10. Eley TC, Hudson JL, Creswell C, et al. Therapy-genetics: The 5HTTLPR and response to psychological therapy. Molecular Psychiatry. 2012;17(3): 236-7. doi: 10.1038/mp.2011.132
  11. Karg K, Burmeister M, Shedden K, et al. The Serotonin Transporter Promoter Variant (5-HTTLPR), Stress, and Depression Meta-Analysis Revisited: Evidence of Genetic Moderation. Archives of Gene-ral Psychiatry. 2011;68(5):444-54. doi: 10.1001/archgenpsychiatry.2010.189
  12. Steel Z, Marnane C, Iranpour C, et al. The global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013. International Journal of Epidemiology. 2014;43(2):476-93. doi: 10.1093/ije/dyu038
  13. Neznanov NG, Martynikhin IA, Mosolov SN.
  14. Diagnosis and treatment of Anxiety Disorders in Russia: The Results of a Web-based Survey of
  15. Psychiatrists. Sovremennaya terapiya psikhicheskikh rasstroystv. 2017;(2):2-13. doi: 10.21265/PSYPH.2017.41.6437
  16. Gregory AM, Eley TC. The genetic basis of child and adolescent anxiety. In: Silverman W.K., Field A.P., editors. Anxiety Disorders in Children and Adolescents. Cambridge: Cambridge University Press; 2011. P. 161-78.
  17. Stein MB, Schork NJ, Gelernter J. Gene-by-Environment (Serotonin Transporter and Childhood Maltreatment) Interaction for Anxiety Sensitivity, an Intermediate Phenotype for Anxiety Disorders. Neuropsychopharmacology. 2008;33(2):312-9. doi: 10.1038/sj.npp.1301422
  18. Furmark T, Carlbring P, Hammer S, et al. Effects of Serotonin Transporter and Tryptophan Hydroxylase-2 Gene Variation on the Response to Cognitive-Behavior Therapy in Individuals with Social Anxiety Disorder. Biological Psychiatry. 2010;67:1S-271S.
  19. Lonsdorf TB, Ruck C, Bergstrom J, et al. The COMT val158met polymorphism is associated with symptom relief during exposure-based cognitive-behavioral treatment in panic disorder. BMC Psychiatry. 2010;(10):99. doi: 10.1186/1471-244X-10-99
  20. Lester KJ, Hudson J, Tropeano M, et al. Neurotrophic gene polymorphisms and response to psychological therapy. Translational Psychiatry. 2012; 2(5):e108. doi: 10.1038/tp.2012.33
  21. Hedman E, Andersson E, Ljótsson B, et al. Clinical and genetic outcome determinants of Internet and group-based cognitive behavior therapy for social anxiety disorder. Acta Psychiatrica Scandinavica. 2012;126(2):126-36. doi: 10.1111/j.1600-0447.2012.01834.x
  22. Fullana MA, Alonso P, Gratacos M, et al. Variation in the BDNF Val66Met polymorphism and response to cognitive-behavior therapy in obsessive-compulsive disorder. European Psychiatry. 2012; 27(5):386-90. doi: 10.1016/j.eurpsy.2011.09.005
  23. Depressiya v Rossiyskoy Federatsii (2017). Available at: https://www.euro.who.int/ru/countries/russian-federation/data-and-statistics/infographic-depression-in-the-russian-federation-2017. Accessed: 2020 September 25. (In Russ).
  24. Depression. Available at: https://www.who.int/news-room/fact-sheets/detail/depression. Accessed: 2020 September 25.
  25. Sullivan PF, Neale MC, Kendler K. Genetic epidemiology of major depression: review and meta-analysis. The American Journal of Psychiatry. 2000; 157(10):1552-62. doi: 10.1176/appi.ajp.157.10.1552
  26. Anttila V, Bulik-Sullivan B, Finucane HK, et al. Analysis of shared heritability in common disorders of the brain. Science. 2018;360(6395):eaap8757. doi: 10.1126/science.aap8757
  27. Lester KJ, Eley TC. Therapygenetics: Using genetic markers to predict response to psychological treatment for mood and anxiety disorders. Biology of Mood & Anxiety Disorders. 2013;3(1):4. doi: 10.1186/2045-5380-3-4
  28. Kotte A, McQuaid JR, Kelsoe J. HTR2A: Genotypic Predictor of Depression Psychotherapy Treatment Outcome. San Diego, California: 62nd Annual Sci-entific Convention and Meeting of the Society of Biological Psychiatry; 2007.
  29. Bakker JM, Lieverse R, Menne-Lothmann C. Therapygenetics in mindfulness-based cognitive therapy: do genes have an impact on therapy-induced change in real-life positive affective experiences? Translational Psychiatry. 2014;4(4):e384. doi: 10.1038/tp.2014.23
  30. Andersson E, Crowley JJ, Lindefors N, et al. Genetics of response to cognitive behavior therapy in adults with major depression: a preliminary report. Molecular Psychiatry. 2019;24(4):484-90. doi: 10.1038/s41380-018-0289-9
  31. Rayner C, Coleman JRI., Purves KL. A genome-wide association meta-analysis of prognostic out-comes following cognitive behavioural therapy in individuals with anxiety and depressive disorders. Translational Psychiatry. 2019;9(1):150. doi: 10.1038/s41398-019-0481-y
  32. Keesler R, Aguilar-Gaxiola S, Alonso J, et al. Trauma and PTSD in the WHO World Mental Health Surveys. European Journal of Psychotraumatology. 2017;8(suppl 5):1353383. doi: 10.1080/20008198.2017.1353383
  33. Li L, Bao Y, He S, et al. The Association Between Genetic Variants in the Dopaminergic System and Posttraumatic Stress Disorder: A Meta-Analysis.
  34. Medicine. 2016;95(11):e3074. doi: 10.1097/MD.0000000000003074
  35. Castro-Vale I, van Rossum EF, Machado JC, et al. Genetics of glucocorticoid regulation and post-traumatic stress disorder – What do we know?. Neuroscience and Biobehavioral Review. 2016; 63:143-57. doi: 10.1016/j.neubiorev.2016.02.005
  36. Gressier F, Calati R, Balestri M, et al. The 5-HTTLPR polymorphism and post-traumatic
  37. stress disorder: a meta-analysis. Journal of
  38. Traumatic Stress. 2013;26(6):645-53. doi: 10.1002/jts.21855
  39. Bryant RA, Felmingham KL, Falconer EM, et al. Preliminary Evidence of the Short Allele of the Serotonin Transporter Gene Predicting Poor Response to Cognitive Behavior Therapy in Posttraumatic Stress Disorder. Biological Psychiatry. 2010; 67(12):1217-9. doi: 10.1016/j.biopsych.2010.03.016
  40. Wang Z., Harrer J., Tuerk P., et al. 5-HTTLPR Influence PTSD Treatment Outcome. Vancouver, Canada: 64th Annual Scientific Convention and Meeting of the Society of Biological Psychiatry; 2009.
  41. Lau JYF, Eley TC. Changes in genetic and environmental influences on depressive symptoms across adolescence and young adulthood. British Journal of Psychiatry. 2006;189(5):422-7. doi: 10.1192/bjp.bp.105.018721
  42. Eley TC. The future of therapygenetics: where will studies predicting psychological treatment response from genomic markers lead? Depression & Anxiety. 2014;31(8):617-20. doi: 10.1002/da.22292
  43. Fedotov IA, Dorovskaya VA, Nazarov DA. The issue of comorbidity of obsessive-compulsive disorder and schizophrenia. Nauka Molodykh (Eruditio Juvenium). 2016;(2):49-55. (In Russ).

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Eco-Vector, 2021


Media Registry Entry of the Federal Service for Supervision of Communications, Information Technology and Mass Communications (Roskomnadzor) PI No. FS77-76803 dated September 24, 2019.



##common.cookie##